Why can it take decades for translational medicine research to produce clinical benefits?

Translational medicine research often requires decades to produce clinical benefits due to the immense complexity, high costs, and rigorous regulatory requirements inherent in developing new therapies. The process from initial discovery to market can take 10 to 15 years, as thousands of chemical compounds must be screened to identify even a few candidates suitable for clinical testing.12

Several factors contribute to this lengthy timeline:

• Regulatory and Safety Burdens: To ensure public safety and privacy, new treatments must undergo extensive, multi-phase clinical trials. As modern biotechnology becomes more sophisticated, therapeutic agents have grown more complex, making safety and efficacy evaluations more difficult to standardize.1
• Lack of Surrogate Endpoints: For many chronic diseases, the absence of reliable biological markers—or surrogate endpoints—to measure treatment benefits early on can prolong clinical trials by decades.1
• Administrative and Structural Challenges: The current fragmentation of clinical research into rigid, discipline-based administrative structures often hinders the collaborative, goal-oriented approach necessary for efficient translation.1
• Resource Constraints: High costs, limited funding, and the need for specialized training for clinical scientists further complicate the process.1